Pharmaceuticals

Emphysema Treatment Sector Forecast Shows Robust Momentum, Climbing to $7.91 Billion With 8.1% CAGR

February 13, 2026February 13, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the emphysema treatment market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Emphysema Treatment Market expected to reach by 2030?

The emphysema treatment market size has experienced significant expansion recently. This market is set to expand from $5.4 billion in 2025 to $5.8 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The historical growth witnessed in this sector can be attributed to the increasing prevalence of COPD, a growing smoking population, insufficient awareness regarding early diagnosis, the continued adoption of traditional inhalation therapies, and the development of hospital infrastructure in developing regions.

The emphysema treatment market is anticipated to experience substantial growth over the next few years. It is projected to expand to $7.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.1%. This expansion during the forecast period can be attributed to breakthroughs in gene therapy, the increasing adoption of digital health solutions, the development of home healthcare services, the creation of portable oxygen devices, and a growing demand for minimally invasive surgeries. Key trends expected in the forecast period include personalized treatment plans, home-based care options, minimally invasive therapies, telehealth and remote monitoring, and advanced pulmonary rehabilitation programs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What Drivers Are Driving Adoption Within The Emphysema Treatment Market?

An increasing occurrence of chronic obstructive pulmonary disease (COPD) is anticipated to fuel the expansion of the emphysema treatment market. COPD refers to a group of conditions, such as emphysema and chronic bronchitis, which lead to obstructed airflow and challenges in breathing. Emphysema treatments play a crucial role in slowing the progression of COPD by targeting symptoms, helping to restore lung function, and postponing the disease’s advancement. For example, a research study published in December 2023 by JAMA Network Open, a medical journal from the American Medical Association, indicated that the global incidence of COPD could escalate to nearly 600 million cases globally by the year 2050, representing a 23% rise in its prevalence. Consequently, the growing prevalence of chronic obstructive pulmonary disease (COPD) cases is a key driver for the emphysema treatment market.

What Segments Are Included Within The Emphysema Treatment Market?

The emphysema treatment market covered in this report is segmented –

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments

2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies

3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:

1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs

2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics

3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers

4) By Leukotriene Modifiers: Montelukast, Zafirlukast

5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems

6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines

7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides

8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation

9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

Which Market Trends Are Opening Growth Opportunities In The Emphysema Treatment Market?

Leading firms within the emphysema market are pursuing the development of innovative offerings, such as inhalation aerosols, to secure a competitive advantage. These aerosols are pharmaceutical preparations delivered as a fine mist or spray of liquid medicine suspended in a propellant or a combination of propellants. An illustrative instance is the July 2023 introduction of Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol by Viatris Inc., a US-based pharmaceutical company, in partnership with Kindeva Drug Delivery L.P., a US-based pharmaceutical contract development and manufacturing organization (CDMO). This product represents the initial FDA-approved generic alternative to AstraZeneca’s Symbicort, designed for individuals dealing with asthma, chronic obstructive pulmonary disease (COPD), and emphysema. Offered in 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths, this combined drug and device innovation marks a significant step forward in delivering affordable and available treatment solutions for those with respiratory difficulties. Breyna’s purpose includes the ongoing management of airflow obstruction, lessening exacerbations in COPD patients, and controlling asthma symptoms for patients six years and older, encompassing those with emphysema.

Who Are The Major Companies Operating In The Emphysema Treatment Market?

Major companies operating in the emphysema treatment market are AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Emphysema Treatment Market?

North America was the largest region in the emphysema treatment market in 2025. The regions covered in the emphysema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Emphysema Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp

Browse Through More Reports Similar to the Global Emphysema Treatment Market 2026, By The Business Research Company

Emphysema Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Anaphylaxis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

Bronchitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/bronchitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795